STEPHANIE MIRAULT: Open Payments
NPI 1942932322 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 11 payments from 8 companies in 2025. Trend: 2023 $188 · 2024 $125 · 2025 $361
Food & beverage: $343Education: $18
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $152 |
| Alexion Pharmaceuticals, Inc. | 2 | $59 |
| Grifols USA, LLC | 2 | $51 |
| Amgen Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| TerSera Therapeutics LLC | 1 | $16 |
Products named: ULTOMIRIS, Gamunex-C, KRYSTEXXA, VYEPTI, Prolastin-C Liquid, KISUNLA, Quzyttir, TREMFYA.
Industry payments across CO — which companies pay providers there.
